Throughout the postseason, the Baldwin boys basketball team had to put together dramatic rallies on multiple occasions. The Bulldogs overcame an 11-point halftime deficit in their substate ...

NBCUniversal will stop production on multiple programs later this year. Per Deadline, the following shows have been cancelled: “Access Hollywood,” “Access Daily” (formerly Access Live), “The Steve ...

So, you’re wondering which programming language is the absolute hardest to learn in 2026? It’s a question that pops up a lot, especially when you see all the new languages coming out. People often ...

The General Services Administration has released a draft of several changes it plans for the Multiple Award Schedule program, a government-wide initiative for agencies to acquire commercial products ...

Penn State cruised to its fourth straight title at the Big Ten Wrestling Championships, winning a program-record seven individual titles in the process. Penn State also set a school-record with 184 ...

University of North Dakota provides funding as a member of The Conversation US. Throughout February 2026, people at the Kennedy Space Center got to witness an exciting sight: NASA’s behemoth Space ...

A sign for the U.S. Department of State is seen on the outside of the Harry S. Truman Federal Building on Oct. 8, 2024 in Washington, DC. (Photo by Kevin Dietsch/Getty Images) The Department of State ...

Teledyne Technologies Incorporated (NYSE:TDY), a global leader in advanced imaging and sensor solutions, is pleased to announce the start of production on multiple awards to deliver state-of-the-art ...

More than 30 Texas companies, including some in the San Antonio and Austin areas, made the cut for a Pentagon program that Homeland Security can use to build detention sites across the nation. Vendors ...

The state cited Care Crossings for more than 100 breaches of state law or rules. Whistleblowers say the business has long had issues. A new state report has cited a Stillwater-area substance abuse ...

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. The Japanese pharma had been evaluating the alpha-synuclein antibody, called ...